1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
4.1. Product Pipeline
5. UNITED KINGDOM RUO IMMUNOASSAY MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Immunoassay Kits
5.2.1. Enzyme-Linked Immunosorbent Assay (ELISA) Kits
5.2.1.1. Conventional
5.2.1.2. Manual
5.2.2. Radioimmunoassay (RIA Kits)
5.2.2.1. Conventional
5.2.2.2. Manual
5.2.3. Chemiluminescent Immunoassay (CLIA) Kits
5.3. Immunoassay Reagents
5.4. Microplate Reader
5.5. Microplates
5.6. Analyzers
5.6.1. Automated Analyzers
5.6.2. Non-Automated Analyzers
5.7. Microplate Washers
5.8. Others
6. UNITED KINGDOM RUO IMMUNOASSAY MARKET BY SAMPLE TYPE
6.1. Introduction
6.2. Plasma
6.3. Blood Serum
6.4. Urine
6.5. Saliva
6.6. Cell or Tissue Culture Medium
6.7. Others
7. UNITED KINGDOM RUO IMMUNOASSAY MARKET BY APPLICATION
7.1. Introduction
7.2. Oncology
7.3. Blood Screening and Toxicology
7.4. Infectious Disease
7.5. Cardiology
7.6. Allergy Diagnostic
7.7. Rare and Emerging Condition Diagnostic
7.8. Others
8. UNITED KINGDOM RUO IMMUNOASSAY MARKET BY END-USER
8.1. Introduction
8.2. Research and Academic Laboratories
8.3. Pharmaceutical and Biotechnology Companies
9. UNITED KINGDOM RUO IMMUNOASSAY MARKET BY COUNTRIES
9.1. Introduction
9.2. England
9.2.1. By Product Type
9.2.2. By Sample Type
9.2.3. By Application
9.2.4. By End-User
9.3. Scotland
9.3.1. By Product Type
9.3.2. By Sample Type
9.3.3. By Application
9.3.4. By End-User
9.4. Wales
9.4.1. By Product Type
9.4.2. By Sample Type
9.4.3. By Application
9.4.4. By End-User
9.5. Northern Ireland
9.5.1. By Product Type
9.5.2. By Sample Type
9.5.3. By Application
9.5.4. By End-User
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Abcam PLC
11.2. DIAsource Immunoassay
11.3. Danaher
11.4. PerkinElmer, Inc
11.5. Siemens Healthineers
11.6. F. Hoffman La Roche Ltd.
11.7. Merck KGaA
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations